Equity… Patient Engagement in the Pharmaceutical Industry and Investor Perception 13 Oct 202330 Oct 2023 Patient engagement has become an increasingly important factor in the pharmaceutical industry, influencing various aspects of drug development, marketing, post-market surveillance, risk management, investor perception, cost savings, and regulatory and…
Asset Allocation… Healthcare Investments in Asia 9 Oct 202326 Apr 2024 The key macro drivers for healthcare investments in various countries in Asia include demographics, economic growth, healthcare infrastructure, government policies and regulations, technological advancements, disease prevalence, insurance penetration, cultural factors,…
Alternative Investments… Private Equity Market Landscape – First Quarter 2014 4 May 201419 May 2014 The year of 2013 has been the most successful year for private equity firms since 2008, with 873 funds with an aggregate of $454 billion. In 2013, the private equity-backed…
Healthcare Fund… Venture Capital in Life Sciences (III): Monoclonal Antibodies in the Treatment of Ankylosing Spondylitis 16 Apr 201419 Apr 2014 The application of monoclonal antibody drugs is a relatively new innovation. Approximately 54% of monoclonal antibody drugs available are applied in various types of cancer, although clinical trials are also…
Healthcare Fund… Venture Capital in Life Sciences (II): Pharmacogenomics and Personalized Medicine 7 Apr 20147 Apr 2014 Pharmacogenomics focuses on understanding the response rates and side effects of a treatment at the individual level. It analyzes the influence of genetic variation on drug response in patients by…
Healthcare Fund… Biomedicine: Healthcare Venture Capital’s Investment of 2014 30 Mar 20141 Apr 2014 As a venture capitalist, I believe the hottest investment of 2014 is in the healthcare sector. The beauty of healthcare investing lies in the fact that the demand for the…
Alternative Investments… Venture Capital in Life Sciences (I): Personalized Medicine for Cancer Therapies 24 Feb 201417 Mar 2014 Over the past decade, the genomics revolution has led to the emergence of numerous groundbreaking personalized medicine as well as multiple diagnostic and therapeutic targets. Take the area of cancer…
Alternative Investments… Healthcare Investing: In Innovators We Trust, Up to the Future We Light 17 Feb 201422 Feb 2014 When people talk about “healthcare,” they probably refer to pharmaceuticals and health insurers, but the sector also covers life sciences and biotechnology, medical equipment manufacturers and services, hospitals, distributors, etc.…